Skip to main content

Table 12 CN distribution of proteins consistently expressed in cancer samples

From: Modelling human protein interaction networks as metric spaces has potential in disease research and drug target discovery

Type of cancer

# proteins

Zone 1

Zone 2

Zone 3

Zone 4

Zone 5

Breast

350

24 (6.8%)

224 (64%)

95 (27.1%)

7 (2%)

-

Cervical

760

43 (5.6%)

496 (65.2%)

203 (26.7%)

16 (2.1%)

2 (0.2%)

Endometrial

1644

91 (5.5%)

1007 (61.2%)

474 (28.8%)

61 (3.7%)

11 (0.6%)

Fallopian

1408

71 (5%)

869 (61.7%)

409 (29%)

51 (3.6%)

8 (0.5%)

Glioblastoma

1128

63 (5.5%)

719 (63.7%)

311 (27.5%)

30 (2.6%)

5 (0.4%)

Glioma

1270

67 (5.2%)

765 (60.2%)

380 (29.9%)

48 (3.7%)

10 (0.7%)

Kidney

593

44 (7.4%)

389 (65.5%)

150 (25.2%)

10 (1.6%)

-

Liver

769

51 (6.6%)

475 (61.7%)

221 (28.9%)

21 (2.7%)

1 (0.1%)

Lung

571

39 (6.8%)

369 (64.6%)

153 (26.7%)

9 (1.5%)

1 (0.1%)

Ovarian

823

37 (4.4%)

524 (63.6%)

236 (28.6%)

23 (2.7%)

3 (0.3%)

Pancreatic

771

44 (5.7%)

483 (62.6%)

223 (28.9%)

21 (2.7%)

-

Pituitary

1228

60 (4.8%)

738 (60%)

373 (30.3%)

47 (3.8%)

10 (0.8%)

Rectal

1753

96 (5.4%)

1061 (60.5%)

515 (29.3%)

70 (3.9%)

11 (0.6%)

Average

 

5.7%

62.7%

28.2%

2.8%

0.3%